Ian Thompson has been with Ypsomed AG, formerly Disetronic AG, since 1995 in a number of roles in key account management and business development working with pharma companies to develop and bring to market innovative self-injection systems.
He studied biochemistry and biotechnology in the UK from 1979-1983, working initially in commercial roles for fermentation technology. He has worked in medical device companies since moving to Switzerland in 1990.
Since 2003 his main focus has been business development and new product innovation leading to the successful development and launch of a range of new pen and autoinjector Custom Products for Ypsomed Delivery Systems.
Ypsomed Delivery Systems continues to focus on the development and manufacture of next generation pen, autoinjector, wearable and connected injector technologies.